Skip to main content
. 2020 Nov;17(11):1352–1357. doi: 10.1513/AnnalsATS.202005-554CME

Table 3.

Adjunctive medications for critically ill patients receiving long-acting naltrexone requiring analgesia or anxiolysis

Medication Indication Considerations
Dexmedetomidine Anxiolysis and analgesia Dose may be limited by bradycardia and there is risk for withdrawal with prolonged infusion
Nonsteroidal antiinflammatory medications Analgesia Concern for adverse drug reactions and for acute renal injury
Acetaminophen Analgesia May need dose reduction with certain comorbidities, such as liver disease
Ketamine Anxiolysis and analgesia Limited evidence base in critically ill patients, and concern for increased risk of acute delirium in the ICU setting
Gabapentin, pregabalin, carbamazepine Neuropathic pain and anxiolysis Dose reduction required in renal failure and concern for medication interactions with carbamazepine
Dexamethasone Antiinflammatory Multiple adverse effects
Phenobarbital Anxiolysis Prolonged duration of action and potential for medication interactions via cytochrome P450 system
Benzodiazepines Anxiolysis Risk of delirium, prolonged ventilation, and paradoxical reactions
Propofol Sedation and hypnosis Commonly associated with hypotension

Definition of abbreviation: ICU = intensive care unit.